Our findings highlight the importance of β2AR in the promotion of cell cycle progression in proliferating cells and support the β2AR-c-met complex as a novel therapeutic target for abnormal proliferative diseases, such as benign and malignant tumors. The gene discussed is ADRB2; the disease is glycogen storage disease VI.